Niagen Bioscience Inc (NASDAQ:NAGE) price on Friday, May 23, fall -2.76% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $9.88.
A look at the stock’s price movement, the close in the last trading session was $10.16. The PE ratio in trailing twelve months stood at 57.21. Turning to its 52-week performance, $11.06 and $2.31 were the 52-week high and 52-week low respectively. Overall, NAGE moved 33.88% over the past month.
Niagen Bioscience Inc’s market cap currently stands at around $778.24 million, with investors looking forward to this quarter’s earnings report slated for in June.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NAGE is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
The technical evaluation for the stock shows the PEG ratio is 1.54, with NAGE’s current price about 6.72% and 25.94% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 61.29, while 7-day volatility ratio is 2.66% and 3.90% in the 30-day chart. Further, Niagen Bioscience Inc (NAGE) has a beta value of 2.04, and an average true range (ATR) of 0.51.
If we refocus on Niagen Bioscience Inc (NASDAQ:NAGE), historical trading data shows that trading volumes averaged 1.10 million over the past 3 months. The company’s latest data on shares outstanding shows there are 78.43 million shares.
The 36.77% of Niagen Bioscience Inc’s shares are in the hands of company insiders while institutional holders own 31.97% of the company’s shares. Current price change has pushed the stock 86.24% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NAGE stock continues to rise going into the next quarter.
